We’re a leading innovative biopharmaceutical company, enabled by a world-class generics business. Guidelines: https://teapaw.org/t.co/sOC1rpJ9tr
United States
Joined August 2010
- Tweets3.4K
- Following1K
- Followers10.8K
- Likes1.1K
Our Q3 2026 earnings call is starting in 30 minutes. Join CEO Richard Francis live to hear about Teva's business performance and plans for the road ahead.
ow.ly/TBWX5103e19
Forward-looking statements are subject to the cautionary note included in our Q3 2026 press release.
#QuarterlyResults #Earnings $TEVA
Our Q3 2026 financial results are in, as we continue our transformation into a leading biopharma company: ow.ly/IgZZ5103ivT
Forward-looking statements are subject to the cautionary note included in our Q3 2026 press release.
#QuarterlyResults #Earnings $TEVA
Teva announces a new agreement with @SamsungBioepis to commercialize two FDA-approved immunology biosimilars in the U.S.
This agreement will expand our U.S. portfolio, advancing Teva’s Pivot to Growth strategy and driving our transformation into a leading biopharmaceutical company. It also builds on our growing partnership with Samsung Bioepis, including a previously announced global agreement that includes up to six potential biosimilar candidates.
Learn more: tevapharm.com/news-and-media…
Tune in to our Q3 2026 earnings call with CEO Richard Francis and the Teva leadership team on Tuesday, November 3.
Save the date: ow.ly/xG5r5101XqQ
#QuarterlyResults #Q3Results #Earnings $TEVA
Forward-looking statements are subject to the cautionary note included in our Q3 2026 press release.
New long-term maintenance data presented at #UEGWeek, evaluating our investigational treatment option for ulcerative colitis (UC) and Crohn’s disease (CD).
See press release here: ow.ly/LmkO50ZZijG
#TevaPharm $TEVA @sanofi
BREAKING: The FDA has granted approval of our new schizophrenia long-acting treatment option.
Read more from today’s announcement here: ow.ly/9sjW50ZWenA
$TEVA
#News: Research is shedding light on Tourette syndrome in pediatric patients and potential treatment options, with new clinical data presented at #MDSCongress and a review published in @JChildNeurol
See more: tevausa.com/news-and-media/p…
Partnering to improve patient access to life changing medicines: Teva and @SamsungBioepis expand strategic partnership to advance up to six potential biosimilar candidates.
Learn more: tevapharm.com/news-and-media…
BREAKING: Teva receives FDA approval for a new biosimilar treatment to help prevent skeletal-related events in people with certain cancers or bone metastases from solid tumors, and to treat hypercalcemia of malignancy: bit.ly/3VE7xdf $TEVA #PivotToGrowth
At #PsychCongress2026, Teva presents new studies within our innovative medicines portfolio, covering the latest research and real-world evidence in schizophrenia, bipolar I disorder and tardive dyskinesia.
Read the press releases here: ow.ly/cPy250ZNnuO
Today, we are announcing the launch of LongActingImpact.com, a resource built to provide healthcare professionals with practical guidance and insights on utilizing long-acting injectables (LAIs) for #schizophrenia treatment.
Learn more: ow.ly/xAbW50ZOgfh
Teva Pharmaceuticals retweeted
The NYSE welcomes @TevaUSA to celebrate its first day of trading ordinary shares! $TEVA teapaw.org/i/broadcasts/1qKVmybmL…
Exciting #news: Teva achieves Investment Grade from all three leading credit rating agencies, as @SPGlobalRatings joins @moodysratings and @FitchRatings in upgrading Teva’s rating, recognizing the progress we have made to strengthen our financial profile and execute our Pivot to Growth strategy.
Learn more: tevapharm.com/news-and-media…
#Breaking: Teva announces positive topline results from phase 2a study in celiac disease for its anti-il-15 antibody, further validating its pipeline-in-a-product potential.
Join the webcast today at 8:00 am ET: ir.tevapharm.com/Events-and-…
Read the press release: tevapharm.com/news-and-media…
The @US_FDA has accepted Teva’s NDA and granted Priority Review for a potential new treatment option for pediatric patients living with #TouretteSyndrome.
Learn more here: ow.ly/XwzB50ZBqvX
#PivotToGrowth $Teva
Teva Pharmaceuticals retweeted
"It's a pipeline that not only meets unmet medical need – we believe it has a high probability of being successful."
@TevaUSA CEO Richard Francis explains why the company's developing its own drugs instead of sticking strictly with generics:
cnbc.com/video/2026/07/29/wa…
Our Q2 2026 earnings call is starting in 30 minutes. Join CEO Richard Francis live to hear about Teva's business performance and plans ahead.
ow.ly/S0cL50Zu8eo
Forward-looking statements are subject to the cautionary note included in our Q2 2026 press release.
#QuarterlyResults #Earnings $Teva
We are reporting our Q2 2026 financial results, as we continue our transformation into a leading biopharma company
tevapharm.com/news-and-media…
Forward-looking statements are subject to the cautionary note included in our Q2 2026 press release.
#QuarterlyResults #Earnings $Teva
Tune in to our Q2 2026 earnings call with CEO Richard Francis and the Teva leadership team on Wednesday, July 29.
Save the date: ow.ly/2cqp50ZrfPm
#QuarterlyResults #Q2Results #Earnings $Teva
Forward-looking statements are subject to the cautionary note included in our Q2 2026 press release.
